Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study-Reference-Cited by-同舟云学术

Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study

Published:2016-03 Issue:3 Volume:6 Page:e009510
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Mocking Roel J T,Figueroa Caroline A,Rive Maria M,Geugies Hanneke,Servaas Michelle N,Assies Johanna,Koeter Maarten W J,Vaz Frédéric M,Wichers Marieke,van Straalen Jan P,de Raedt Rudi,Bockting Claudi L H,Harmer Catherine J,Schene Aart H,Ruhé Henricus G

Publisher

BMJ

Subject

General Medicine

Reference202 articles.

1. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys;Andrade;Int J Methods Psychiatr Res,2003

2. The burden of recurrent depression: causes, consequences, and future prospects;Greden;J Clin psychiatry,2001

3. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010;Vos;Lancet,2012

4. Cross-national epidemiology of DSM-IV major depressive episode;Bromet;BMC Med,2011

5. Projections of global mortality and burden of disease from 2002 to 2030;Mathers;PLoS Med,2006

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic features of treatment-refractory major depressive disorder with suicidal ideation;Translational Psychiatry;2023-12-15

2. Depression recurrence is accompanied by longer periods in default mode and more frequent attentional and reward processing dynamic brain‐states during resting‐state activity;Human Brain Mapping;2023-09-06

3. Experience of clinical use of fluvoxamine for the treatment of comorbid depression in childhood and adolescence;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

4. Suicidal ideation in remitted major depressive disorder predicts recurrence;Journal of Psychiatric Research;2022-07

5. Effect and neural mechanisms of the transcutaneous vagus nerve stimulation for relapse prevention in patients with remitted major depressive disorder: protocol for a longitudinal study;BMJ Open;2022-02